Search

everythinglearnresearchcommunity

for

Search:↓

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

Some men don't respond to common hair loss treatments, but a new inhibitor, FOL-005, shows promise for targeting unwanted hair growth.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Platelet-Rich Plasma (PRP) treatment can significantly increase hair count and thickness in people with Androgenetic Alopecia (AGA) with minimal side effects.

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

Finasteride helps hair growth but may cause sexual side effects and depression.

Iron deficiency in menstruating women causes many health issues beyond anemia and needs early detection and treatment.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Man experienced lasting sexual dysfunction from finasteride, but malpractice claim was rejected.